ct colon ography

Upload: daniel-situngkir

Post on 03-Jun-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 Ct Colon Ography

    1/29

    CT Colonography vs Colonoscopyfor the Detection of Advanced

    Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K. Leung,

    M.D., Thomas C. Winter, M.D., J. Louis Hinshaw, M.D., Deepak V. Gopal, M.D., Mark Reichelderfer, M.D., Richard H. Hsu, M.D., and Patrick R. Pfau, M.D.

    NEJM Oct 4, 2007 Volume 357:1403-1412

  • 8/12/2019 Ct Colon Ography

    2/29

    Background

  • 8/12/2019 Ct Colon Ography

    3/29

    Ct Colonography

    http://www.radiologyinfo.org/en/photocat/photos_pc.cfm?image=vcoloMovie.jpg&pg=ct_colo

    http://www.radiologyinfo.org/en/photocat/photos_pc.cfm?image=vcoloMovie.jpg&pg=ct_colo
  • 8/12/2019 Ct Colon Ography

    4/29

    Colorectal cancer:

    A major cause of cancer-relatedmortality in the US (55,000 deaths/yr)

    Preventable by detection and removal ofits precursor:

    advanced colonic adenoma

  • 8/12/2019 Ct Colon Ography

    5/29

    Colonic adenoma progression

    Small adenomas< 5mm dysplasia

    Advance colonicadenomas>10mm Cancer

    10 yrs

    Most likelyHyperplastic

    Usually do not progress to cancer

  • 8/12/2019 Ct Colon Ography

    6/29

    Study Objective

  • 8/12/2019 Ct Colon Ography

    7/29

    Optical colonoscopy (OC) is currently

    the preferred screening and preventivestrategy of CRC by AGS

    CT colonography (CTC) is a non-invasive promising alternative screeningmethod

    Most trials examining CTC had failed toshow comparative sensitivity/specificityto OC.

  • 8/12/2019 Ct Colon Ography

    8/29

    Methods

  • 8/12/2019 Ct Colon Ography

    9/29

    Study design: Single center, nonrandomize clinical trial comparing CTCvs OC screening in a 25 month period

    Study population: 6283 pt referred by primary care providers.

    3120 CTC screening 3163 OC screening

  • 8/12/2019 Ct Colon Ography

    10/29

  • 8/12/2019 Ct Colon Ography

    11/29

    Inclusion/Exclusion criteria Inclusion

    Asymptomatic and average risk for

    colorectal CA Exclusion

    Prior polyp surveillance

    History of bowel disorder (IBD, polyposis syndromes, hereditary non polyposis colorectal cancer syndrome)

  • 8/12/2019 Ct Colon Ography

    12/29

    Screening Methods

    Pt identified with advanced neoplasm(mass/polyps > 6mm) by CTC were given theoption of surveillance with CTC or removal ofthe polyp by OC.

    In the OC group, All polyps/masses found wereremoved, regardless of size or significance.

    All removed masses were evaluated for locationrelative to the splenic flexure, morphologiccharacteristics, and histology.

  • 8/12/2019 Ct Colon Ography

    13/29

    Screening Methods

    Lesions were divided into two categories: Polyps

    Large: > 10mm Small: 6-9 mm Diminutive: 5mm or less

    Invasive mass

  • 8/12/2019 Ct Colon Ography

    14/29

    Statistics

    A positive test was defined as detectionof polyps of any size in the OC groupand polyps of >6mm in the CTC group.

    The two tests were compared usingstudents T -test and Chi squareanalyses

  • 8/12/2019 Ct Colon Ography

    15/29

    Results

  • 8/12/2019 Ct Colon Ography

    16/29

  • 8/12/2019 Ct Colon Ography

    17/29

  • 8/12/2019 Ct Colon Ography

    18/29

  • 8/12/2019 Ct Colon Ography

    19/29

    3120 Patients were enrolled inCTC screening

    Routine follow-up in 5 yrs

    2716 (87.1%) had negativefindings

    404 (12.9%) had positivefindings

    With 394 polyps (>6mm)

    158 (5.1%) chose ongoingimaging surveillance

    227 adenomas

    246 (7.9%) underwent OC with polypectomy

    With 193 polyps

    123 Advanced neoplastic lesions

    14 Cancers 153 non-neoplastic tumors

  • 8/12/2019 Ct Colon Ography

    20/29

  • 8/12/2019 Ct Colon Ography

    21/29

  • 8/12/2019 Ct Colon Ography

    22/29

    More Information

  • 8/12/2019 Ct Colon Ography

    23/29

    Summary of Results Both CTC and OC had comparative

    diagnostic yield for both types of advanceneoplasia (p= 0.81)

    CTC had an advantage of safety, norequirement for sedation, and detectingextra-colonic abnormalities

    There were larger number of polypectomiesin the OC (2434) vs. in the CTC (561) whiletotal advance neoplasias were similar in both

    (121/2434 vs 123/561)

  • 8/12/2019 Ct Colon Ography

    24/29

    PPV for advance neoplasia

    TP / TP+FP

    CTC 123 / 561

    OC 121 / 2434

  • 8/12/2019 Ct Colon Ography

    25/29

    Discussion

  • 8/12/2019 Ct Colon Ography

    26/29

    Study Strength

    Large sample size, similar baselinecharacteristics

    Relevant exclusion criteria

    Detailed pathological characterization oftissues in addition to imaging to establishcomparative detection

    Could have significant clinical andeconomical impact on current practice ofcolon CA screening

  • 8/12/2019 Ct Colon Ography

    27/29

    Weakness Non blinded/non-randomized (selection

    bias)

    single Center Technical advancement may vary betweencenters for effective CTC screening

    True negatives in pts with lesions < 5mm inthe CTC group is not determined

  • 8/12/2019 Ct Colon Ography

    28/29

    Clinical Practice Relevance

    Offers CTC as a non-invasive alternative toOC for comparative detection of colonicneoplasias

    Eliminates the need for a large number ofunnecessary colonoscopies and

    polypectomies

    Due to variability in technical resourcesCTC may not yet be a potential replacementfor OC in many practice settings

  • 8/12/2019 Ct Colon Ography

    29/29

    Thank you